¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2022-07-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2022-07-23
±³À°ÀÏÀÚ : 2022-07-23
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï B1 ±×·£µåȦ  
±³À°ÁÖÁ¦ : 2022 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷°ü¿¬±¸È¸  
´ã´çÀÚ : ÀÌÀ¯¸®
¿¬¶ôó : 02-701-7023  
À̸ÞÀÏ : kvrwg@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í 1. »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ (30,000¿ø) / Àü°øÀÇ, ÀüÀÓÀÇ, ±âŸ (20,000¿ø) 2. ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ (50,000¿ø) / Àü°øÀÇ, ÀüÀÓÀÇ, ±âŸ (30,000¿ø)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-23 ±×·£µåȦ 08:40~08:55 Pathophysiology of aortic aneurysm: what¡¯s new?  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 08:55~09:10 Role of peri-aortic fat in aortic atherosclerosis  ÃÖ¼ºÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 09:10~09:25 Non-atherosclerotic aortopathy: not to be missed  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 09:25~09:40 Novel medical treatment in aortopathy and aneurysm  ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 07-23 ±×·£µåȦ 09:40~10:00 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 10:00~10:15 Summary of recent treatment guideline in aortic disease  ¹Ú»ó¹Î(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 10:15~10:30 Use of multimodal imaging for evaluation and intervention  ±¹Çüµ·(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 10:30~10:45 Screening and medical treatment of inflammatory aorta disease: A rheumatologist¡¯ viewpoint  È«¼®Âù(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 10:45~11:00 Recent advances in the treatments for thoraco-abdominal aortic diseases  ±èÁعü(¿ï»êÀÇ´ë) 
Åä·Ð 07-23 ±×·£µåȦ 11:00~11:20 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ07-23 ±×·£µåȦ 11:20~11:40 Coffee Break  () 
±³À°½Ã°£ 07-23 ±×·£µåȦ 11:40~11:55 Immune response and vascular health  ½ÅÀÇö(KAIST) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 11:55~12:10 Vascular wall as an outside-in controller of graft dysfunction?  ¼ºÇÐÁØ(¿¬¼¼´ë) 
Åä·Ð 07-23 ±×·£µåȦ 12:10~12:30 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 12:30~13:20 First HF treatment with ARNI: Restore Heart, Restore Life  ½ÅÁ¤ÈÆ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 13:20~13:35 Ç÷°ü°æÁ÷µµ ÃøÁ¤, °á°ú°ªÀÌ ³Ê¹« ¸¹¾Æ¿ä. ¹» ºÁ¾ß Çϳª¿ä?  ÀÌÈñ¼±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 13:35~13:50 °æµ¿¸Æ ÃÊÀ½ÆÄ °Ë»ç, ¾ðÁ¦ ¾î¶»°Ô ÇÒ °ÍÀΰ¡?  ÃÖÀÚ¿¬(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 13:50~14:05 º¹ºÎ´ëµ¿¸Æ·ù °Ë»ç, ¾ðÁ¦ ¾î¶»°Ô ÇÒ °ÍÀΰ¡?  ¹ÚÁø¼±(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 14:05~14:20 ÇÏÁöµ¿¸Æ(´ëÅ𵿸Æ) °Ë»ç ¹× °¡¼ºµ¿¸Æ·ù Ä¡·á  ±è¿ìÇö(ÇѾçÀÇ´ë) 
Åä·Ð 07-23 ±×·£µåȦ 14:20~14:40 Questions Young Cardiologists  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ07-23 ±×·£µåȦ 14:40~15:00 Coffee Break  () 
±³À°½Ã°£ 07-23 ±×·£µåȦ 15:00~15:10 Introduction of Bioengineering for Collaboration  ¹ÚÁöÈ£(KAIST) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 15:10~15:30 Computer simulation of intravascular flow  ÇÏÇö¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 15:30~15:50 Digital therapy for vascular disease  ¹ÚÁØ»ó(È«ÀÍ´ë) 
Åä·Ð 07-23 ±×·£µåȦ 15:50~16:10 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 16:10~16:25 Antiplatelet agents other than aspirin/P2Y12 inhibitor: does it work?  ÀÌÁØ¿ø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 16:25~16:40 Ginko biloba extract: does it work?  ÃÖ°­¿î(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 07-23 ±×·£µåȦ 16:40~16:55 Drugs for veno-lympathic dysfunction: mechanism and effects  ±èÅÂÈÆ(Â÷ÀÇ´ë) 
Åä·Ð 07-23 ±×·£µåȦ 16:55~17:15 Panel Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2022-07-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎÇÏ´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú IGR ½ÉÆ÷Áö¾ö : 2022-07-23
´ÙÀ½±Û Á¦ 7Â÷ ÀÌÈ­ÀÇ·á¿ø ·Îº¿¼ö¼ú ½ÉÆ÷Áö¾ö : 2022-07-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 598 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,073 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 905 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 533 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,134 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 841 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,213 2018-07-28
287 ¼­¿ï 2018 ´ëÇÑâ»óÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2018-09-29 0 608 2018-07-28
286 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(CSC treatment update) : 2018-09-28 0 1,082 2018-07-28
285 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) ÇǺΠÇ÷°ü Áúȯ 2) »ö¼Ò ÀÌ»óÁõ : 2018-09-27 0 758 2018-07-28
284 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(Æó¼â°¢ ³ì³»Àå) : 2018-09-21 0 1,415 2018-07-28
283 ´ë±¸ ´ëÇѽÅÀåÇÐȸ ´ë±¸-°æºÏÁöȸ ¿¬¼ö °­Á : 2018-09-20 0 652 2018-07-28
282 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-20 0 387 2018-07-28
281 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] 4Â÷ »ê¾÷Çõ¸í°ú ÀÇ·áÀÇ ¹Ì·¡ : 2018-09-20 0 633 2018-07-28
280 ¼­¿ï ¼­¿ïƯº°½ÃÀÇ»çȸ Á¦5Â÷ ȸ¿ø¿¬¼ö±³À°(Áø´Ü¸í¿¡ µû¸¥ ÀûÀýÇÑ Ã³¹æ) : 2018-09-20 0 847 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷